LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on advanced breast cancer
Disease control OngoingThis study is testing whether adding an immunotherapy drug (atezolizumab) to a targeted cancer drug (olaparib) works better than the targeted drug alone for people with advanced breast cancer that has a specific genetic flaw (BRCA mutation). The goal is to see if the combination …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new drug duo in fight against spreading breast cancer
Disease control OngoingThis early-stage trial is testing a combination of two drugs, cyclophosphamide and veliparib, for people with advanced breast cancer that has spread. The main goal is to find the safest and most effective dose of this drug pair. Researchers will also check if certain markers in a…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC